| 2026-08-21 | Presentation | August 2026 Corporate Presentation |
| 2026-08-21 | Press release | Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards |
| 2026-08-12 | Press release | Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates |
| 2026-07-15 | Press release | Azitra, Inc. Announces Breakthrough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Inc |
| 2026-06-17 | Press release | Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Be |
| 2026-06-16 | Press release | Azitra, Inc. to Present at 2026 BIO International Convention |
| 2026-06-04 | Press release | Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting |
| 2026-05-27 | Press release | Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting |
| 2026-05-13 | Press release | Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates |
| 2026-05-06 | Press release | Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program |
| 2026-04-28 | Press release | Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris |
| 2026-03-19 | Press release | Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Ap |
| 2026-03-13 | Press release | Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement |
| 2026-03-05 | Press release | Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders |
| 2026-02-27 | Press release | Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates |
| 2026-02-24 | Press release | Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EG |
| 2026-02-19 | Press release | Azitra, Inc. to Present at BIO Investment & Growth Summit |
| 2026-02-06 | Press release | Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting |
| 2026-01-07 | Press release | Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference |
| 2025-10-20 | Press release | Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris |
| 2025-10-15 | Press release | Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit |
| 2025-09-04 | Press release | Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference |
| 2025-08-27 | Press release | Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi- |
| Press release | Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome |